查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629212

葡萄糖耐受性測試市場，按產品類型、按疾病適應症、按最終用戶、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Glucose Tolerance Test Market, By Product Type, By Disease Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，葡萄糖耐受性測試市場規模為2,692,043萬美元，2024年至2032年複合年成長率為6.60%。

葡萄糖耐受性測試市場-市場動態

全球糖尿病發生率上升推動市場需求

全球糖尿病盛行率的不斷上升是推動全球葡萄糖耐受性測試市場成長的主要因素。例如，預計到 2045 年，全球糖尿病發生率將從 2021 年的 5.37 億增至 7.83 億。方案預計將推動市場成長。然而，低度開發地區的高成本和醫療服務受限可能會阻礙市場成長。相反，深度學習和機器人技術在診斷行業的整合以及政府對糖尿病治療和診斷研發的資助的增加預計將在預測期內為市場提供巨大的成長機會。

葡萄糖耐受性測試市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.60% 左右的複合年成長率成長

根據產品類型細分，預計血糖檢測試劑盒將在 2023 年呈現最大市場佔有率

根據疾病適應症細分，2023年糖尿病低血糖為主導細分

按地區分類，北美葡萄糖耐受性測試市場是 2023 年的主要收入來源

葡萄糖耐受性測試市場-細分分析：

全球葡萄糖耐受性測試市場根據產品類型、疾病適應症、最終用戶和地區進行細分。

市場依產品類型分為四大類：血糖檢測套件、智慧感測器、儀表等。血糖檢測試劑盒產業佔市場主導地位。智慧感測器技術和無縫物聯網連接的進步正在推動市場成長。

根據最終用戶，市場分為兩類：家庭護理環境、醫院和診所、診斷中心等。醫院和診所行業在市場中佔據主導地位，並可能在預測期內保持其主導地位。這主要是由於他們處理的患者量很大，並且可以使用先進的診斷工具來進行準確、高效的葡萄糖耐受性測試。

葡萄糖耐受測試市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

葡萄糖耐受性測試市場-競爭格局：

人們對糖尿病早期檢測的認知不斷增強，並付出了努力，推動了市場的發展。公司正在優先考慮策略合作，以加強研究和開發先進的診斷解決方案。為了保持競爭力，參與者正在投資尖端技術，例如數位健康整合，以實現更好的血糖監測。此外，透過併購擴大全球影響力是一個重點，因為它有助於豐富產品線並進入未開發的市場，提高整體競爭力和市場影響力。

最新進展：

2024 年 8 月，DirectSens 推出了 XpressGT RUO 套件，用於診斷妊娠糖尿病、子宮內膜異位症、胰島素抗性和肝病等疾病。 XpressGT 與標準臨床分析儀相容，只需 8 分鐘即可提供結果，測量靜脈血液中的 2-羥基丁酸 (2-HB) 水平，當該水平升高時，表明潛在的內分泌和代謝紊亂。

目錄

第1章：葡萄糖耐受性測試市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的葡萄糖耐受性測試市場片段
    • 按疾病指示分類的葡萄糖耐受性測試市場片段
    • 最終用戶的葡萄糖耐受性測試市場片段
    • 按國家/地區分類的葡萄糖耐受性測試市場片段
    • 按地區分類的葡萄糖耐受性測試市場片段
  • 競爭洞察

第 3 章：葡萄糖耐受性測試主要市場趨勢

  • 葡萄糖耐受性測試市場促進因素
    • 市場促進因素的影響分析
  • 糖耐量測試市場限制
    • 市場限制影響分析
  • 葡萄糖耐受測試市場機會
  • 葡萄糖耐受性測試市場未來趨勢

第 4 章：葡萄糖耐受性測試產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：葡萄糖耐受性測試市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：葡萄糖耐受性測試市場格局

  • 2023 年葡萄糖耐受性測試市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：葡萄糖耐受性測試市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 血糖測試套件
    • 智慧感測器
    • 米
    • 其他

第 8 章：葡萄糖耐受性測試市場 - 按疾病適應症

  • 概述
    • 按疾病適應症分類的細分市場佔有率分析
    • 糖尿病低血糖
    • 反應性低血糖
    • 妊娠糖尿病
    • 其他

第 9 章：葡萄糖耐受性測試市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 家庭護理設置
    • 醫院和診所
    • 診斷中心
    • 其他

第 10 章：葡萄糖耐受性測試市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美葡萄糖耐受性測試主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（按疾病適應症）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲葡萄糖耐受性測試主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按疾病適應症）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區葡萄糖耐受測試主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依疾病適應症）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲葡萄糖耐受測試主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按疾病適應症）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲葡萄糖耐受測試主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（依疾病指示）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-葡萄糖耐受測試產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • NIPRO
    • Medtronic
    • Trividia Health, Inc.
    • Healius Limited
    • Dexcom, Inc.
    • Penlan Healthcare Ltd.
    • Johnson & Johnson Services, Inc.
    • Quest Diagnostics Incorporated
    • Abbott
    • Laboratory Corporation of America Holdings
    • Cleveland HeartLab, Inc.
    • ARUP Laboratories
    • Merck KGaA
    • Ascensia Diabetes Care Holdings AG
    • Bayer AG
    • E-Zlab Health Services
    • LifeScan IP Holdings, LLC
    • F. Hoffman-La Roche Ltd.
    • Sanofi
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4441

REPORT HIGHLIGHT

Glucose tolerance test market size was valued at USD 26,920.43 Million in 2023, expanding at a CAGR of 6.60% from 2024 to 2032.

A glucose tolerance test (GTT) is a diagnostic tool used to evaluate the body's response to sugar intake, primarily for diagnosing diabetes. It includes an oral glucose tolerance test (OGTT), where blood glucose levels are measured before and after consuming a glucose solution. High glucose levels may indicate impaired sugar absorption by body cells. A simpler version, the glucose challenge test, involves a single blood test following glucose intake.

Glucose Tolerance Test Market- Market Dynamics

Increasing rate of diabetes worldwide to propel market demand

The growing prevalence of diabetes among people across the globe is the major factor driving the growth of the global glucose tolerance test market. For instance, the global incidence of diabetes is expected to rise to 783 million by 2045, up from 537 million in 2021. Besides, increasing awareness of diabetes mellitus in densely populated regions, combined with significant investments in the design and development of large-scale diagnostic solutions, is expected to fuel market growth. However, high costs and restricted access to medical services in underdeveloped regions may hamper the market growth. On the contrary, the integration of deep learning and robotics in the diagnostic industry and increased government funding for research and development in diabetes therapeutics & diagnostics are predicted to provide massive growth opportunities for the market during the forecast period.

Glucose Tolerance Test Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.60% over the forecast period (2024-2032)

Based on product type segmentation, blood glucose test kit was predicted to show maximum market share in the year 2023

Based on disease indication segmentation, diabetes hypoglycemia was the leading segment in 2023

On the basis of region, the North America glucose tolerance test market was the leading revenue generator in 2023

Glucose Tolerance Test Market- Segmentation Analysis:

The Global Glucose Tolerance Test Market is segmented on the basis of Product Type, Disease Indication, End User, and Region.

The market is divided into four categories based on product type: blood glucose testing kit, smart sensors, meters, and others. The blood glucose testing kit sector dominates the market. Advancements in smart sensor technology and seamless IoT connectivity are driving the market growth.

The market is divided into two categories based on end user: homecare settings, hospitals & clinics, diagnostic centers, and others. The hospitals & clinics sector dominates the market and is likely to maintain its dominance during the forecast period. This is mainly due to the high patient volume they handle and the availability of advanced diagnostic tools for accurate and efficient glucose tolerance testing.

Glucose Tolerance Test Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Glucose Tolerance Test Market- Competitive Landscape:

The market is propelled by growing awareness and efforts for early diabetes detection. Companies are prioritizing strategic collaborations to enhance research and develop advanced diagnostic solutions. To stay competitive, players are investing in cutting-edge technologies, like digital health integration, for better glucose monitoring. Additionally, expanding global presence through mergers and acquisitions is a key focus, as it helps diversify product lines and reach untapped markets, boosting their overall competitiveness and market influence.

Recent Developments:

In August 2024, DirectSens has introduced the XpressGT RUO kit for diagnosing conditions like Gestational Diabetes, Endometriosis, Insulin Resistance, and Liver Disease. Compatible with standard clinical analyzers, XpressGT provides results in just 8 minutes, measuring 2-hydroxybutyrate (2-HB) levels in venous blood, which, when elevated, indicate potential endocrine and metabolic disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GLUCOSE TOLERANCE TEST MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • NIPRO
  • Medtronic
  • Thermo Fisher Scientific Inc.
  • NIPRO
  • Medtronic
  • Trividia Health, Inc.
  • Healius Limited
  • Dexcom, Inc.
  • Penlan Healthcare Ltd.
  • Johnson & Johnson Services, Inc.
  • Quest Diagnostics Incorporated
  • Abbott
  • Laboratory Corporation of America Holdings
  • Cleveland HeartLab, Inc.
  • ARUP Laboratories
  • Merck KGaA
  • Ascensia Diabetes Care Holdings AG
  • Bayer AG
  • E-Zlab Health Services
  • LifeScan IP Holdings, LLC
  • F. Hoffman-La Roche Ltd.
  • Sanofi
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood Glucose Testing Kit
  • Smart Sensors
  • Test Slips
  • Meters
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Diabetes Hypoglycemia
  • Reactive Hypoglycemia
  • Gestational Diabetes
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Homecare Settings
  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

GLOBAL GLUCOSE TOLERANCE TEST MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Glucose Tolerance Test Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Glucose Tolerance Test Market Snippet by Product Type
    • 2.1.2. Glucose Tolerance Test Market Snippet by Disease Indication
    • 2.1.3. Glucose Tolerance Test Market Snippet by End User
    • 2.1.4. Glucose Tolerance Test Market Snippet by Country
    • 2.1.5. Glucose Tolerance Test Market Snippet by Region
  • 2.2. Competitive Insights

3. Glucose Tolerance Test Key Market Trends

  • 3.1. Glucose Tolerance Test Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Glucose Tolerance Test Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Glucose Tolerance Test Market Opportunities
  • 3.4. Glucose Tolerance Test Market Future Trends

4. Glucose Tolerance Test Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Glucose Tolerance Test Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Glucose Tolerance Test Market Landscape

  • 6.1. Glucose Tolerance Test Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Glucose Tolerance Test Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Blood Glucose Testing Kit
    • 7.1.3. Smart Sensors
    • 7.1.4. Meters
    • 7.1.5. Others

8. Glucose Tolerance Test Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 8.1.2. Diabetes Hypoglycaemia
    • 8.1.3. Reactive Hypoglycaemia
    • 8.1.4. Gestational Diabetes
    • 8.1.5. Others

9. Glucose Tolerance Test Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Homecare Settings
    • 9.1.3. Hospitals & Clinics
    • 9.1.4. Diagnostic Centers
    • 9.1.5. Others

10. Glucose Tolerance Test Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Glucose Tolerance Test Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Glucose Tolerance Test Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Glucose Tolerance Test Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Glucose Tolerance Test Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Glucose Tolerance Test Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Glucose Tolerance Test Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. NIPRO
    • 11.2.3. Medtronic
    • 11.2.4. Trividia Health, Inc.
    • 11.2.5. Healius Limited
    • 11.2.6. Dexcom, Inc.
    • 11.2.7. Penlan Healthcare Ltd.
    • 11.2.8. Johnson & Johnson Services, Inc.
    • 11.2.9. Quest Diagnostics Incorporated
    • 11.2.10. Abbott
    • 11.2.11. Laboratory Corporation of America Holdings
    • 11.2.12. Cleveland HeartLab, Inc.
    • 11.2.13. ARUP Laboratories
    • 11.2.14. Merck KGaA
    • 11.2.15. Ascensia Diabetes Care Holdings AG
    • 11.2.16. Bayer AG
    • 11.2.17. E-Zlab Health Services
    • 11.2.18. LifeScan IP Holdings, LLC
    • 11.2.19. F. Hoffman-La Roche Ltd.
    • 11.2.20. Sanofi
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us